Wedge Capital Management L L P NC Has $4.80 Million Stock Position in Sabra Healthcare REIT, Inc. $SBRA

Wedge Capital Management L L P NC boosted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 12.8% in the 2nd quarter, Holdings Channel reports. The firm owned 245,826 shares of the real estate investment trust’s stock after buying an additional 27,822 shares during the period. Wedge Capital Management L L P NC’s holdings in Sabra Healthcare REIT were worth $4,796,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of SBRA. Rothschild Investment LLC increased its stake in shares of Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 889 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares during the last quarter. Strengthening Families & Communities LLC acquired a new stake in Sabra Healthcare REIT in the fourth quarter valued at about $29,000. Versant Capital Management Inc boosted its stake in Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 603 shares in the last quarter. Finally, Danske Bank A S bought a new position in Sabra Healthcare REIT in the third quarter valued at about $30,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Up 1.7%

Shares of SBRA stock opened at $20.19 on Thursday. Sabra Healthcare REIT, Inc. has a twelve month low of $17.17 and a twelve month high of $22.77. The stock’s fifty day simple moving average is $19.92 and its 200 day simple moving average is $20.00. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $5.16 billion, a P/E ratio of 77.66, a P/E/G ratio of 1.53 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm had revenue of $230.11 million during the quarter, compared to the consensus estimate of $219.39 million. During the same quarter in the prior year, the business posted $0.38 earnings per share. Sabra Healthcare REIT’s revenue for the quarter was up 24.7% compared to the same quarter last year. As a group, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.9%. The ex-dividend date is Friday, August 14th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 461.54%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Raymond James Financial raised Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Scotiabank decreased their price target on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Barclays began coverage on shares of Sabra Healthcare REIT in a research report on Tuesday, July 7th. They set an “overweight” rating and a $21.00 price objective for the company. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Finally, Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, August 4th. Seven investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Sabra Healthcare REIT has an average rating of “Moderate Buy” and an average price target of $22.25.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.